Strona 4 - Najlepsi lekarze do leczenia raka odbytnicy – TOP 115 lekarzy

Dr Alon Pikarsky posiada ponad 25-letnie doświadczenie chirurgiczne w leczeniu raka odbytnicy w Centrum Medycznym Hadassah.

• Specjalizuje się w chirurgii kolorektalnej, pełniąc liczne funkcje akademickie i kliniczne
• Posiada certyfikat specjalisty w dziedzinie chirurgii ogólnej od 1998 roku
• Kieruje programami rezydentury chirurgicznej od 2000 roku
• Jest starszym wykładowcą chirurgii od 2005 roku

Dr Ayala Hubert kieruje Centrum Raka Przewodu Pokarmowego w Centrum Medycznym Hadassah. Posiada 33-letnie doświadczenie skoncentrowane na onkologii i radioterapii.

• Specjalizuje się w onkologii klinicznej i radioterapii
• Pełni funkcję ordynatora Centrum Raka Przewodu Pokarmowego
• Posiada certyfikat specjalisty w dziedzinie onkologii i radioterapii
• Jest członkiem Izraelskiego Towarzystwa Onkologii Klinicznej
• Wykształcenie zdobyła na Uniwersytecie Hebrajskim oraz w Szpitalu Uniwersyteckim Hadassah

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Dr Ercan Ozden kształcił się na prestiżowym Uniwersytecie Stambulskim. Specjalizuje się w onkologii klinicznej, ze szczególnym uwzględnieniem raka odbytnicy.

• Ukończył podspecjalizację z onkologii klinicznej na Uniwersytecie Kocaeli
• Posiada ponad dziesięcioletnie doświadczenie w zakresie chorób wewnętrznych
• Praktykował w wielu renomowanych szpitalach w Turcji
• Ukończył anglojęzyczny program medyczny na Uniwersytecie Stambulskim

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr Kinas specjalizuje się w chirurgii onkologicznej i kolorektalnej. Posiada bogate doświadczenie w leczeniu raka odbytnicy w szpitalach Büyük Anadolu.

• Biegle posługuje się zarówno tradycyjnymi, jak i zaawansowanymi technikami chirurgicznymi
• Koncentruje się na operacjach nowotworów trzustki, dróg żółciowych oraz jelita grubego
• Posiada również doświadczenie w chirurgii bariatrycznej, metabolicznej oraz leczeniu operacyjnym cukrzycy

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr Joseba Rebollo Liceaga posiada ponad 30-letnie doświadczenie w dziedzinie onkologii. Specjalizuje się w leczeniu raka odbytnicy w Quironsalud Torrevieja.

• Przez 13 lat kierował oddziałem onkologii w Clínica San Miguel de Navarra
• Jest autorem prac badawczych na temat elektrochemioterapii oraz leczenia wielodyscyplinarnego
• Uzyskał specjalizację z onkologii klinicznej w Clínica Universidad de Navarra
• Pracuje jako lekarz asystent na Wydziale Medycyny Uniwersytetu Nawarry

Ponad 15 000 zabiegów chirurgicznych w ciągu 25 lat – dr de Lacy specjalizuje się w technikach małoinwazyjnych w leczeniu raka odbytnicy w Hospital Quiron Barcelona.

• Wykonuje ponad 1000 operacji małoinwazyjnych rocznie
• Jest pionierem techniki TaTME w leczeniu raka odbytnicy
• Pełni funkcję prezesa Europejskiego Stowarzyszenia Chirurgów Endoskopowych
• Wykłada zaawansowane techniki laparoskopowe

Dr Zalmanova specjalizuje się w radioterapii raka odbytnicy w Centrum Medycznym Assuta.

• Radioterapeuta koncentrujący się na leczeniu raka odbytnicy
• Pracuje w Centrum Medycznym Assuta, wiodącej placówce onkologicznej
• Zajmuje się opracowywaniem spersonalizowanych planów leczenia dla każdego pacjenta

Prof. Thomas W. Kraus wykonał ponad 3000 interwencji chirurgicznych, specjalizując się w złożonych zabiegach żołądkowo-jelitowych i trzustkowych w klinice Nordwest.

• Założył i kieruje niemieckim towarzystwem „Sztuka Chirurgii” (Art of Surgery).
• Uznany w skali krajowej specjalista w dziedzinie chirurgii trzustki.
• Stosuje techniki małoinwazyjne oraz wizualizację śródoperacyjną.
• Jest członkiem FACS i został uhonorowany licznymi nagrodami chirurgicznymi.

Absolwentka Uniwersytetu Hacettepe z wyróżnieniem, specjalizuje się w żywieniu pacjentów onkologicznych oraz opiece po operacjach bariatrycznych.

• Prowadziła badania nad związkiem między żywieniem a chorobami przewlekłymi
• Odbyła staże w czołowych szpitalach, w tym w Szpitalu Onkologicznym Uniwersytetu Hacettepe
• Ukończyła specjalistyczne kursy z zakresu żywienia bariatrycznego i leczenia otyłości
• Pracuje z różnymi grupami pacjentów, w tym z osobami chorymi na raka i cukrzycę